{"id":397763,"date":"2020-12-10T16:08:14","date_gmt":"2020-12-10T21:08:14","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=397763"},"modified":"2020-12-10T16:08:14","modified_gmt":"2020-12-10T21:08:14","slug":"bioasis-announces-annual-general-meeting-results","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/bioasis-announces-annual-general-meeting-results\/","title":{"rendered":"Bioasis Announces Annual General Meeting Results"},"content":{"rendered":"
\n

GUILFORD, Conn., Dec. 10, 2020 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC<\/u><\/strong><\/a>\u2013Bioasis Technologies Inc. (TSX.V:BTI; OTCQB:BIOAF) (the \u201cCompany\u201d or \u201cBioasis\u201d), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3\u2122<\/sup> platform technology for the delivery of therapeutics across the blood-brain barrier (\u201cBBB\u201d) and the treatment of central nervous system (\u201cCNS\u201d) disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases, is pleased to announce that all resolutions were passed by requisite majority at its annual general meeting (\u201cAGM\u201d) held earlier today in New Haven, Conn., United States.<\/p>\n

The four incumbent directors, Dr. Deborah A. Rathjen, John E. Curran, David M. Wurzer and Dr. Mario Saltarelli were re-elected by shareholders. Mr. John Hemeon was also elected to the Board by shareholders, bringing the total number of directors to five. Shareholders also approved the re-appointment of Manning Elliott LLP as auditors of the Company for the ensuing year.<\/p>\n

\n On behalf of the Board of Directors of Bioasis Technologies Inc.<\/strong>\n <\/p>\n

Deborah Rathjen, Ph.D., Executive Chair
deborah@bioasis.us
+1 203 533 7082<\/p>\n

Follow on:
Twitter<\/a>
LinkedIn<\/a>
Facebook<\/a>
BTI-CRP<\/p>\n

\n About Bioasis<\/strong>
\n
Bioasis Technologies Inc. is a biopharmaceutical company developing the xB3<\/sup> platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases. The delivery of therapeutics across the blood brain barrier represents the final frontier in treating neurological disorders. The in-house development programs at Bioasis are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders. The Company maintains headquarters in Guilford, Conn., United States. Bioasis trades on the TSX Venture Exchange under the symbol \u201cBTI\u201d and on the OTCQB under the symbol \u201cBIOAF.\u201d For more information about the Company, please visit www.bioasis.us<\/a>.<\/p>\n

\n Forward Looking Statements<\/strong>
\n
Certain statements in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 or forward-looking information under applicable Canadian securities legislation that may not be based on historical fact along with other statements containing the words \u201cbelieve,\u201d \u201cmay,\u201d \u201cplan,\u201d \u201cwill,\u201d \u201cestimate,\u201d \u201ccontinue,\u201d \u201canticipate,\u201d \u201cintend,\u201d \u201cexpect\u201d and similar expressions. Such forward-looking statements or information involve known and unknown risks, uncertainties and other factors that may cause our actual results, events or developments, or industry results, to be materially different from any future results, events or developments express or implied by such forward-looking statements or information. Such factors include, among others, our stage of development, lack of any product revenues, additional capital requirements, risk associated with the completion of clinical trials and obtaining regulatory approval to market our products, the ability to protect our intellectual property, dependence on collaborative partners and the prospects for negotiating additional corporate collaborations or licensing arrangements and their timing. Specifically, certain risks and uncertainties that could cause such actual events or results expressed or implied by such forward-looking statements and information to differ materially from any future events or results expressed or implied by such statements and information include, but are not limited to, the risks and uncertainties that: products that we develop may not succeed in preclinical or clinical trials, or future products in our targeted corporate objectives; our future operating results are uncertain and likely to fluctuate; we may not be able to raise additional capital; we may not be successful in establishing additional corporate collaborations or licensing arrangements; we may not be able to establish marketing and the costs of launching our products may be greater than anticipated; we have no experience in commercial manufacturing; we may face unknown risks related to intellectual property matters; we face increased competition from pharmaceutical and biotechnology companies; and other factors as described in detail in our filings with the Canadian securities regulatory authorities at www.sedar.com. Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements and information, which are qualified in their entirety by this cautionary statement. All forward-looking statements and information made herein are based on our current expectations and we undertake no obligation to revise or update such forward-looking statements and information to reflect subsequent events or circumstances, except as required by law.<\/p>\n

\n Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.<\/em>\n <\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

GUILFORD, Conn., Dec. 10, 2020 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC\u2013Bioasis Technologies Inc. (TSX.V:BTI; OTCQB:BIOAF) (the \u201cCompany\u201d or \u201cBioasis\u201d), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3\u2122 platform technology for the delivery of therapeutics across the blood-brain barrier (\u201cBBB\u201d) and the treatment of central nervous system (\u201cCNS\u201d) disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases, is pleased to announce that all resolutions were passed by requisite majority at its annual general meeting (\u201cAGM\u201d) held earlier today in New Haven, Conn., United States. The four incumbent directors, Dr. Deborah A. Rathjen, John E. Curran, David M. Wurzer and Dr. Mario Saltarelli were re-elected by shareholders. Mr. John Hemeon was also elected to the Board … <\/p>\n

Continue reading “Bioasis Announces Annual General Meeting Results”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-397763","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nBioasis Announces Annual General Meeting Results - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bioasis-announces-annual-general-meeting-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bioasis Announces Annual General Meeting Results - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"GUILFORD, Conn., Dec. 10, 2020 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC\u2013Bioasis Technologies Inc. (TSX.V:BTI; OTCQB:BIOAF) (the \u201cCompany\u201d or \u201cBioasis\u201d), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3\u2122 platform technology for the delivery of therapeutics across the blood-brain barrier (\u201cBBB\u201d) and the treatment of central nervous system (\u201cCNS\u201d) disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases, is pleased to announce that all resolutions were passed by requisite majority at its annual general meeting (\u201cAGM\u201d) held earlier today in New Haven, Conn., United States. The four incumbent directors, Dr. Deborah A. Rathjen, John E. Curran, David M. Wurzer and Dr. Mario Saltarelli were re-elected by shareholders. Mr. John Hemeon was also elected to the Board … Continue reading "Bioasis Announces Annual General Meeting Results"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/bioasis-announces-annual-general-meeting-results\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-10T21:08:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDQ2NCMzODY2NjI0IzIxOTkzNTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioasis-announces-annual-general-meeting-results\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioasis-announces-annual-general-meeting-results\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Bioasis Announces Annual General Meeting Results\",\"datePublished\":\"2020-12-10T21:08:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioasis-announces-annual-general-meeting-results\\\/\"},\"wordCount\":731,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioasis-announces-annual-general-meeting-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEwMDQ2NCMzODY2NjI0IzIxOTkzNTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioasis-announces-annual-general-meeting-results\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioasis-announces-annual-general-meeting-results\\\/\",\"name\":\"Bioasis Announces Annual General Meeting Results - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioasis-announces-annual-general-meeting-results\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioasis-announces-annual-general-meeting-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEwMDQ2NCMzODY2NjI0IzIxOTkzNTc=\",\"datePublished\":\"2020-12-10T21:08:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioasis-announces-annual-general-meeting-results\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioasis-announces-annual-general-meeting-results\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioasis-announces-annual-general-meeting-results\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEwMDQ2NCMzODY2NjI0IzIxOTkzNTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEwMDQ2NCMzODY2NjI0IzIxOTkzNTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioasis-announces-annual-general-meeting-results\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bioasis Announces Annual General Meeting Results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bioasis Announces Annual General Meeting Results - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/bioasis-announces-annual-general-meeting-results\/","og_locale":"en_US","og_type":"article","og_title":"Bioasis Announces Annual General Meeting Results - Market Newsdesk","og_description":"GUILFORD, Conn., Dec. 10, 2020 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC\u2013Bioasis Technologies Inc. (TSX.V:BTI; OTCQB:BIOAF) (the \u201cCompany\u201d or \u201cBioasis\u201d), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3\u2122 platform technology for the delivery of therapeutics across the blood-brain barrier (\u201cBBB\u201d) and the treatment of central nervous system (\u201cCNS\u201d) disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases, is pleased to announce that all resolutions were passed by requisite majority at its annual general meeting (\u201cAGM\u201d) held earlier today in New Haven, Conn., United States. The four incumbent directors, Dr. Deborah A. Rathjen, John E. Curran, David M. Wurzer and Dr. Mario Saltarelli were re-elected by shareholders. Mr. John Hemeon was also elected to the Board … Continue reading \"Bioasis Announces Annual General Meeting Results\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/bioasis-announces-annual-general-meeting-results\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-10T21:08:14+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDQ2NCMzODY2NjI0IzIxOTkzNTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioasis-announces-annual-general-meeting-results\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioasis-announces-annual-general-meeting-results\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Bioasis Announces Annual General Meeting Results","datePublished":"2020-12-10T21:08:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioasis-announces-annual-general-meeting-results\/"},"wordCount":731,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioasis-announces-annual-general-meeting-results\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDQ2NCMzODY2NjI0IzIxOTkzNTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioasis-announces-annual-general-meeting-results\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/bioasis-announces-annual-general-meeting-results\/","name":"Bioasis Announces Annual General Meeting Results - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioasis-announces-annual-general-meeting-results\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioasis-announces-annual-general-meeting-results\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDQ2NCMzODY2NjI0IzIxOTkzNTc=","datePublished":"2020-12-10T21:08:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioasis-announces-annual-general-meeting-results\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/bioasis-announces-annual-general-meeting-results\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioasis-announces-annual-general-meeting-results\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDQ2NCMzODY2NjI0IzIxOTkzNTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDQ2NCMzODY2NjI0IzIxOTkzNTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioasis-announces-annual-general-meeting-results\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Bioasis Announces Annual General Meeting Results"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/397763","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=397763"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/397763\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=397763"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=397763"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=397763"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}